DEK and prostate cancer: Among the candidates unique to our study are several proteins described to be involved in different cancer types in humans: for example, NOLC1 in multidrug resistant non-small cell lung cancer (the same cancer MALAT1 has originally been identified) [33], DEK in breast cancer [34] and SUB1 in prostate cancer [35].